𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Immune Derangement in Patients with Malignant Melanoma

✍ Scribed by M. G. LEWIS; T. M. PHILLIPS; P. B. NOBLE; D. P. HARTMANN

Book ID
109381045
Publisher
John Wiley and Sons
Year
1979
Tongue
English
Weight
487 KB
Volume
6
Category
Article
ISSN
0303-6987

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Estrogen receptors in patients with mali
Estrogen receptors in patients with malignant melanoma
✍ Edward T. Creagan; James N. Ingle; John E. Woods; Douglas J. Pritchard; Nai-Sian πŸ“‚ Article πŸ“… 1980 πŸ› John Wiley and Sons 🌐 English βš– 213 KB πŸ‘ 2 views
Active specific immunization in malignan
Active specific immunization in malignant melanoma
✍ Gercovich, Felipe G. ;Gutterman, Jordan U. ;Maviigit, Giora M. ;Hersh, Evan M. πŸ“‚ Article πŸ“… 1975 πŸ› John Wiley and Sons 🌐 English βš– 640 KB

## Abstract The effects of active specific immunization with nonirradiated autologous and irradiated cultured allogeneic melanoma tumor cells (TC) on cell‐associated immunity was studied in 11 patients with widespread malignant melanoma receiving chemoimmunotherapy. Immunization with 1 Γ— 10^6^‐8 Γ—

Immune responsiveness of patients with m
Immune responsiveness of patients with malignant melanoma and carcinoma of the breast
✍ Loren Humphrey; Om Singla Ms πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 498 KB

Lymphocyte blastogenesis (LB) with PHA, CON-A, PWM, V,, (homologous tumor extract) plus T/B ratio for pre-IT, post-IT (2 months), and 3, 6, 9, 12, 18, and 24 months prior to each V,, booster are reported. Pre-IT and post-IT LB-PHA were similar for Stage I (ST I) or Stage I1 (ST 11) breast cancer (BC